Based on limited published evidence, ZNF92 is a zinc finger protein predicted to function as a DNA-binding transcription factor. UniProt annotations indicate it likely regulates transcription through RNA polymerase II-specific binding to cis-regulatory regions and possesses zinc ion binding capability. A heterozygous missense variant in ZNF92, when combined with CLN6 variants, has been associated with bipolar disorder susceptibility in one family study 1. Additionally, ZNF92 expression patterns were altered in hepatocellular carcinoma cells treated with atorvastatin, suggesting potential involvement in statin response 2. However, the precise molecular mechanisms and biological significance of ZNF92 function remain unclear.